Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Coutu

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Virology|December 6, 2015
A Highly Conserved Residue of the HIV-1 gp120 Inner Domain Is Important for Antibody-Dependent Cellular Cytotoxicity Responses Mediated by Anti-cluster A AntibodiesShilei Ding, Maxime Veillette, Mathieu Coutu, et al.
Molecular Cancer Therapeutics|June 21, 2024
Anti-Claudin-2 Antibody-Drug Conjugates for the Treatment of Colorectal Cancer Liver MetastasisSébastien Tabariès, Alma Robert, Anne Marcil, et al.
Journal of Virology|December 20, 2013
Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicityMaxime Veillette, Anik Désormeaux, Halima Medjahed, et al.
Ebiomedicine|February 13, 2016
Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated CytotoxicityJonathan Richard, Maxime Veillette, Shilei Ding, et al.
Journal of Virology|March 24, 2017
BST-2 Expression Modulates Small CD4-Mimetic Sensitization of HIV-1-Infected Cells to Antibody-Dependent Cellular CytotoxicityJonathan Richard, Jérémie Prévost, Benjamin von Bredow, et al.
Journal of Virology|January 20, 2017
Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity ResponsesJérémie Prévost, Daria Zoubchenok, Jonathan Richard, et al.
Ebiomedicine|September 17, 2016
Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope GlycoproteinsJonathan Richard, Beatriz Pacheco, Neelakshi Gohain, et al.
Antibody Therapeutics|September 24, 2025
Broadly reactive anti-VHH antibodies for characterizing, blocking, or activating nanobody-based CAR-T cellsScott McComb, Bianca Dupont, Alex Shepherd, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Virology|December 6, 2015
A Highly Conserved Residue of the HIV-1 gp120 Inner Domain Is Important for Antibody-Dependent Cellular Cytotoxicity Responses Mediated by Anti-cluster A AntibodiesShilei Ding, Maxime Veillette, Mathieu Coutu, et al.
Molecular Cancer Therapeutics|June 21, 2024
Anti-Claudin-2 Antibody-Drug Conjugates for the Treatment of Colorectal Cancer Liver MetastasisSébastien Tabariès, Alma Robert, Anne Marcil, et al.
Journal of Virology|December 20, 2013
Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicityMaxime Veillette, Anik Désormeaux, Halima Medjahed, et al.
Ebiomedicine|February 13, 2016
Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated CytotoxicityJonathan Richard, Maxime Veillette, Shilei Ding, et al.
Journal of Virology|March 24, 2017
BST-2 Expression Modulates Small CD4-Mimetic Sensitization of HIV-1-Infected Cells to Antibody-Dependent Cellular CytotoxicityJonathan Richard, Jérémie Prévost, Benjamin von Bredow, et al.
Journal of Virology|January 20, 2017
Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity ResponsesJérémie Prévost, Daria Zoubchenok, Jonathan Richard, et al.
Ebiomedicine|September 17, 2016
Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope GlycoproteinsJonathan Richard, Beatriz Pacheco, Neelakshi Gohain, et al.
Antibody Therapeutics|September 24, 2025
Broadly reactive anti-VHH antibodies for characterizing, blocking, or activating nanobody-based CAR-T cellsScott McComb, Bianca Dupont, Alex Shepherd, et al.
Pageof 2